Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Vane

Showing results (131-140 of 425) with videos related to

Pageof 43
Sort By:
Lancet (London, England)|November 19, 1977
Antithrombotic properties of vascular endotheliumS Bunting, S Moncada, J R Vane
British Journal of Pharmacology|May 1, 1996
Effects of the endothelin receptor antagonist, SB 209670, on circulatory failure and organ injury in endotoxic shock in the anaesthetized ratH Ruetten, C Thiemermann, J R Vane
British Journal of Pharmacology|May 1, 1994
The effects of the endothelin ETA receptor antagonist, FR 139317, on infarct size in a rabbit model of acute myocardial ischaemia and reperfusionL McMurdo, C Thiemermann, J R Vane
Biochemical and Biophysical Research Communications|October 29, 1993
Dihydropyridine antagonists and agonists of calcium channels inhibit the induction of nitric oxide synthase by endotoxin in cultured macrophagesC Szabó, C Thiemermann, J R Vane
International Review of Experimental Pathology|January 1, 1982
Prostacyclin in physiology and pathophysiologyJ R Vane, S Bunting, S Moncada
Prostaglandins|October 1, 1977
The effects of prostacyclin (PGI2) on tissues which detect prostaglandins (PG'S)C Omini, S Moncada, J R Vane
Proceedings. Biological Sciences|September 22, 1993
Inhibition of the production of nitric oxide and vasodilator prostaglandins attenuates the cardiovascular response to bacterial endotoxin in adrenalectomized ratsC Szabó, C Thiemermann, J R Vane
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1992
The two-step conversion of big endothelin 1 to endothelin 1 and degradation of endothelin 1 by subcellular fractions from human polymorphonuclear leukocytesS Kaw, M Hecker, J R Vane
European Journal of Pharmacology|June 23, 1994
The endothelin ETB receptor agonist, IRL 1620, causes vasodilatation and inhibits ex vivo platelet aggregation in the anaesthetised rabbitL McMurdo, C Thiemermann, J R Vane
British Medical Bulletin|July 1, 1983
The prostacyclin--thromboxane A2 balance: pathophysiological and therapeutic implicationsS Bunting, S Moncada, J R Vane
Pageof 43

Showing results (131-140 of 425) with videos related to

Sort By:
Pageof 43
Lancet (London, England)|November 19, 1977
Antithrombotic properties of vascular endotheliumS Bunting, S Moncada, J R Vane
British Journal of Pharmacology|May 1, 1996
Effects of the endothelin receptor antagonist, SB 209670, on circulatory failure and organ injury in endotoxic shock in the anaesthetized ratH Ruetten, C Thiemermann, J R Vane
British Journal of Pharmacology|May 1, 1994
The effects of the endothelin ETA receptor antagonist, FR 139317, on infarct size in a rabbit model of acute myocardial ischaemia and reperfusionL McMurdo, C Thiemermann, J R Vane
Biochemical and Biophysical Research Communications|October 29, 1993
Dihydropyridine antagonists and agonists of calcium channels inhibit the induction of nitric oxide synthase by endotoxin in cultured macrophagesC Szabó, C Thiemermann, J R Vane
International Review of Experimental Pathology|January 1, 1982
Prostacyclin in physiology and pathophysiologyJ R Vane, S Bunting, S Moncada
Prostaglandins|October 1, 1977
The effects of prostacyclin (PGI2) on tissues which detect prostaglandins (PG'S)C Omini, S Moncada, J R Vane
Proceedings. Biological Sciences|September 22, 1993
Inhibition of the production of nitric oxide and vasodilator prostaglandins attenuates the cardiovascular response to bacterial endotoxin in adrenalectomized ratsC Szabó, C Thiemermann, J R Vane
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1992
The two-step conversion of big endothelin 1 to endothelin 1 and degradation of endothelin 1 by subcellular fractions from human polymorphonuclear leukocytesS Kaw, M Hecker, J R Vane
European Journal of Pharmacology|June 23, 1994
The endothelin ETB receptor agonist, IRL 1620, causes vasodilatation and inhibits ex vivo platelet aggregation in the anaesthetised rabbitL McMurdo, C Thiemermann, J R Vane
British Medical Bulletin|July 1, 1983
The prostacyclin--thromboxane A2 balance: pathophysiological and therapeutic implicationsS Bunting, S Moncada, J R Vane
Pageof 43